CPDC & adMare Radiopharmaceutical Initiative (CARI)

What is CARI?

CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare)

The Centre for Probe Development and Commercialization (CPDC)

adMare BioInnovations (adMare)

CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) where we will bring respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain considerable global competitive advantage: RADIOPHARMACEUTICALS. The objective of CARI is for CPDC and adMare to seek out and uncover radiopharmaceutical opportunities arising from academic discoveries and early enterprises, establish rigorous drug development programs around selected opportunities, and drive the generation of proof-of-principle and other data supportive of the commercialization of new radiopharmaceutical assets.

Program Offerings

Biologics Validation & Support

Chemistry Manufacturing & Controls

Radiochemistry Research Consultation

Regulatory Affairs

Business Development

Commercialization & IP Strategies

Presentations & Webinars

To learn more about CARI download our presentation:

Still have Questions? Consult our FAQ or watch our webinar recording:

Letter of Intent (LOI)

Let us know about your project and how CARI can help accelerate your agent to the next level. To submit an application please fill out the following form.

CARI Blog Series

“A Unique Initiative for Radiopharmaceutical Drug Development in Canada”

 

CARI Blog #1: Radiopharmaceuticals: a new class of drugs for cancer patients, and a new road for Canada to lead global life sciences

The role of radiopharmaceuticals in health care may still be quite a mystery for many Canadians, but this area has a tremendous therapeutic and commercial potential. The Centre for Probe Development Commercialization and adMare BioInnovations present you with a series of blogs about radiopharmaceuticals as part of CARI, a collaboration between the two organizations to advance this area in Canada.